Category: Medications

  • All Posts
  • Events
  • Medications
  • Studies
Tava liv (Levofloxacin): Targeted Treatment for Respiratory Infections

February 23, 2026

1. What is Tava liv? Tava liv is a prescription broad-spectrum antibiotic containing Levofloxacin, available in 500 mg and 750 mg strengths. It belongs to the fluoroquinolone class of antimicrobial agents and is engineered to target and eliminate bacterial pathogens causing moderate to severe respiratory tract infections. 2. Key Clinical Indications Tava liv is clinically...

Zivastine: Next-Generation 24-Hour Relief from Allergic Rhinitis & Chronic Urticaria

February 23, 2026

1. What is Zivastine? Zivastine is a second-generation, long-acting histamine H1​-receptor antagonist formulated with Ebastine. Developed to provide comprehensive control over allergic reactions, Zivastine targets both respiratory symptoms and dermatological allergy manifestations. Manufactured by Zein Pharma, Zivastine is delivered in modern Orodispersible Tablets (ODT) across flexible 10 mgand 20 mg dosage strengths. The fast-dissolving formulation...

Zaksan: Next-Generation Anticoagulation for Stroke Prevention and Clot Protection

February 23, 2026

1. What is Zaksan? Zaksan is an advanced prescription anticoagulant containing the active substance Apixaban. Available in 2.5 mg and 5 mg film-coated tablets (30-tablet packs), Zaksan belongs to the modern class of Direct Oral Anticoagulants (DOACs). It is clinically formulated to inhibit harmful blood clot formation in veins and arteries while supporting steady, unobstructed...

Zasek: Advanced Acid Suppression & Gastric Protection

February 23, 2026

1. What is Zasek? Zasek is an advanced prescription gastrointestinal therapy containing Esomeprazole, the purified (S)-enantiomer of omeprazole. As a second-generation Proton Pump Inhibitor (PPI), Zasek delivers powerful, long-lasting reduction of gastric acid production. It is engineered to heal mucosal damage, relieve painful heartburn symptoms, and protect the upper gastrointestinal tract from acid-mediated injury. 2....

No Cholest: Dual-Action Cholesterol Management & Cardiovascular Support

February 23, 2026

1. What is No Cholest? No Cholest is a targeted prescription lipid-lowering agent formulated with Ezetimibe (or as a synergistic combination therapy with statins/nutraceutical lipid complexes). Unlike traditional medications that focus solely on liver cholesterol synthesis, No Cholest acts selectively at the brush border of the small intestine to block dietary and biliary cholesterol absorption,...

Blog Category

Trending Posts

Blog Tag

    • All Posts
    • Events
    • Medications
    • Studies
    Load More

    End of Content.

    Committed to advancing global healthcare through the development, manufacturing, and distribution of high-quality pharmaceutical formulations.

    Contact Info
    Phone: +963986000022
    E-Mail: info@zein-pharma.com

    © 2026 Zein Pharma. All rights reserved.